Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...
MEDevice Boston, the premier MedTech event connecting top OEMs (Original Equipment Manufacturers) with emerging suppliers and strategic partners, has announced its lineup of distinguished keynote ...
In October, Boston Scientific announced plans to dive into the peripheral nerve stimulation space through the acquisition of medtech company Nalu Medical. Boston Scientific has been a Nalu investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results